Pimecrolimus
ATC D11AH02 · 9 markets · 18 records
US 6 records · 1 strengths
- 10 mgtopicalNo trade name
AU 3 records · 3 strengths
- 1 %topicalELIDEL
- 10 mg/gtopicalELIDEL pimecrolimus 1% w/w cream tube
Records without a stated strength · 1 ELIDEL
GB 2 records · 1 strengths
Records without a stated strength · 1 Elidel 1% cream
CA 1 records · 1 strengths
- 1 %topicalELIDEL
SG 1 records · 1 strengths
- 10 mg/gtopicalELIDEL CREAM 1% w/w
ES 1 records · 1 strengths
- 1 %topicalELIDEL
TW 1 records · 1 strengths
Records without a stated strength · 1 Elidel 1% cream、醫立妥乳膏1%
HK 1 records · 1 strengths
Records without a stated strength · 1 Elidel 1% cream
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK |
|---|---|---|---|---|---|---|---|---|
| 1 % topical | ELIDEL | ELIDEL | ELIDEL | |||||
| 10 mg/g topical | ELIDEL pimecrolimus 1% w/w cream tube | ELIDEL CREAM 1% w/w | ||||||
| 10 mg topical | No trade name | |||||||
topical | Elidel 1% cream | Elidel 1% cream 醫立妥乳膏1% | ||||||
unknown | ELIDEL | Elidel 1% cream |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.